What is CAMP4 THERAPEUTICS CORPORATION (CAMP) stock price today?

CAMP4 THERAPEUTICS CORPORATION (CAMP) currently trades at $4.01 per share. The stock has a market capitalization of $230.55M and a P/E ratio of —x.

Is CAMP stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, CAMP4 THERAPEUTICS CORPORATION has a Smart Value Score of 21/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is CAMP4 THERAPEUTICS CORPORATION's revenue and earnings?

CAMP4 THERAPEUTICS CORPORATION has trailing twelve-month (TTM) revenue of $3.50M with profit margins of 0.00%. Earnings per share (EPS) is $-2.65.

CAMP

CAMP4 THERAPEUTICS CORPORATION

NASDAQ: CAMP · HEALTHCARE · BIOTECHNOLOGY

$4.01

-6.09% today

Updated 2026-04-29

Market cap

$230.55M

P/E ratio

—

P/S ratio

65.91x

EPS (TTM)

$-2.65

Dividend yield

—

52W range

$1 – $8

Volume

0.2M

Market cap

$230.55M

P/E ratio

—

P/S ratio

65.91x

EPS (TTM)

$-2.65

Dividend yield

—

52W range

$1 – $8

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

2.7

Growth

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$8.20

+104.49%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy4 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Free cash flow $6.29M — positive

Risks

- Thin margins at 0.00%

- Revenue declining -46.60% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$294.95M	$350000.00	$652000.00	$3.50M	$3.50M
Net income	$-44.19M	$-49.29M	$-51.79M	$-80.40M	$-40.28M
EPS	—	—	—	—	$-2.65
Free cash flow	$-42.57M	$-44.83M	$-46.00M	$-29.83M	$6.29M
Profit margin	-14.98%	-14,083.14%	-7,943.40%	-2,298.54%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CAMP	$230.55M	21	2.7	2.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

CAMP4 THERAPEUTICS CORPORATION trades at $4.01. Our Smart Value Score of 21/100 indicates the stock is weak. TTM revenue stands at $3.50M.

Frequently asked questions

What is CAMP4 THERAPEUTICS CORPORATION's stock price?

CAMP4 THERAPEUTICS CORPORATION (CAMP) trades at $4.01.

Is CAMP4 THERAPEUTICS CORPORATION overvalued?

Smart Value Score 21/100 (Grade F, Strong Sell).

What is the price target of CAMP4 THERAPEUTICS CORPORATION (CAMP)?

The analyst target price is $8.20, representing +104.5% upside from the current price of $4.01.

What is CAMP4 THERAPEUTICS CORPORATION's revenue?

TTM revenue is $3.50M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio65.91x

ROE-145.10%

Beta—

50D MA$4.65

200D MA$3.74

Shares out0.05B

Float0.03B

Short ratio—

Avg volume0.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

CAMP vs LLY →CAMP vs JNJ →CAMP vs ABBV →Stock screener →